Cargando…
Specific IgA against Pseudomonas aeruginosa in severe COPD
BACKGROUND: The bronchial mucosa is protected by a specialized immune system focused on the prevention of colonization and infection by potentially pathogenic microorganisms (PPMs). Immunoglobulin A (IgA) is the principal antibody involved in this mechanism. A defective immune barrier may facilitate...
Autores principales: | Millares, Laura, Martí, Sara, Ardanuy, Carmen, Liñares, Josefina, Santos, Salud, Dorca, Jordi, García-Nuñez, Marian, Quero, Sara, Monsó, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628678/ https://www.ncbi.nlm.nih.gov/pubmed/29033561 http://dx.doi.org/10.2147/COPD.S141701 |
Ejemplares similares
-
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa
por: Millares, L., et al.
Publicado: (2014) -
The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions
por: Millares, Laura, et al.
Publicado: (2022) -
Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae
por: Millares, Laura, et al.
Publicado: (2012) -
Functional Metagenomics of the Bronchial Microbiome in COPD
por: Millares, Laura, et al.
Publicado: (2015) -
The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
por: Millares, Laura, et al.
Publicado: (2017)